Edgewood Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Edgewood Management's LLY Position: Q1 2026 in Review
Edgewood Management reduced its Eli Lilly (LLY) stake by 45% in Q1 2026, selling an estimated $570M and leaving 693,457 shares worth $638M. The position accounts for 4.12% of the portfolio, ranked #12.
Edgewood Management first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.06B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Edgewood Management held 693,457 shares of Eli Lilly worth $638M as of Q1 2026.
- Edgewood Management sold 562,232 Eli Lilly shares in Q1 2026, an estimated $570M.
- Eli Lilly made up 4.12% of Edgewood Management's portfolio in Q1 2026, its #12 holding.
- Edgewood Management first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
- Edgewood Management's Eli Lilly position peaked at $2.06B in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Edgewood Management's 13F filing for Q1 2026, filed 14 May 2026.